Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 31
Back to Home
BPC-157
Healing Rate95%
Studies6
Participants95
StatusAvailable

BPC-157

Body Protection Compound-157

BPC-157 is a pentadecapeptide composed of 15 amino acids derived from body protective compound found in human gastric juice. This synthetic peptide demonstrates remarkable healing and regenerative properties across multiple tissue types including muscle, tendon, ligament, bone, and gastrointestinal tract. While primarily research-stage, BPC-157 has shown consistent protective effects in over 100 preclinical studies, making it one of the most promising healing peptides under investigation.

Complete Research Database

Dual Receptor Mechanism (GIP/GLP-1)

GLP-1 Receptor Pathway

  • Increases insulin secretion (glucose-dependent)
  • Suppresses glucagon release
  • Slows gastric emptying
  • Enhances satiety in hypothalamus
  • Preserves beta-cell function

GIP Receptor Pathway

  • Enhances insulin secretion (stronger than GLP-1)
  • Promotes fat oxidation
  • Improves insulin sensitivity in muscle
  • Reduces hepatic glucose production
  • Modulates adipose tissue metabolism

Why Dual Agonism is Superior

BPC-157 exerts its healing effects through multiple molecular pathways including activation of the VEGFR2-Akt-eNOS signaling pathway, promotion of angiogenesis via VEGF upregulation, modulation of growth factor expression (PDGF-BB, EGF, FGF), and interaction with the nitric oxide system. It stabilizes gastric pentadecapeptide BPC 157 by counteracting leaky gut syndrome, promotes collagen synthesis, and demonstrates cytoprotective effects through antioxidant mechanisms and mitochondrial protection.

Pharmacokinetic Profile

~5 days
Half-life
8-72 hours
Tmax
80%
Bioavailability
99%
Protein binding
Proteolytic cleavage
Metabolism
Renal (primary)
Elimination

Top 10 High-Quality Research Articles

Search PubMed for 'BPC-157' or 'body protection compound' for additional peer-reviewed research on this healing and protection peptide.

Medical Disclaimer

BPC-157 is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Any use should occur only under medical supervision in approved research settings.